Rankings
▼
Calendar
SLDB Q3 2019 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena
SLDB
Solid Biosciences Inc.
$581M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$30M
Net Income
-$29M
EPS (Diluted)
$-10.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$20M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$131M
Total Liabilities
$22M
Stockholders' Equity
$109M
Cash & Equivalents
$95M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$30M
-$19M
-55.2%
Net Income
-$29M
-$19M
-53.8%
← FY 2019
All Quarters
Q4 2019 →